Ledger.Open graph →
SEC Form D · filed December 31, 2025

Cadrenal Therapeutics, Inc

Offering
$4.4M
Sold
$4.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PONTE VEDRA, FL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

John R. Murphy · PONTE VEDRA, FLDirectorMatthew K. Szot · Longmont, COExecJeffrey K. Cole · PONTE VEDRA, FLExecQuang X. Pham · PONTE VEDRA, FLExec · DirectorGlynn J. Wilson · PONTE VEDRA, FLDirectorSteven J. Zelenkofske · PONTE VEDRA, FLDirectorLee S. Golden · Livonia, MIDirectorJames J. Ferguson · PONTE VEDRA, FLExecJohn R. Murphy · PONTE VEDRA, FLDirectorLee S. Golden · Livonia, MIDirectorMatthew K. Szot · Hanford, CAExecJeffrey K. Cole · PONTE VEDRA, FLExecQuang X. Pham · PONTE VEDRA, FLExec · DirectorJames J. Ferguson · PONTE VEDRA, FLExecGlynn J. Wilson · PONTE VEDRA, FLDirectorSteven J. Zelenkofske · PONTE VEDRA, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗